Management of erythromelalgia: a narrative review and expert opinion.

IF 3.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY
Jumana Aldhalaan, Julio C Sartori-Valinotti, Mark Denis P Davis, Paola Sandroni
{"title":"Management of erythromelalgia: a narrative review and expert opinion.","authors":"Jumana Aldhalaan, Julio C Sartori-Valinotti, Mark Denis P Davis, Paola Sandroni","doi":"10.1080/14656566.2026.2734121","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Erythromelalgia (EM) is a rare disorder predominantly affecting distal extremities characterized by episodes of painful burning erythema, often precipitated by heat and exercise. Treatment is challenging due to limited evidence and lack of guidelines.</p><p><strong>Areas covered: </strong>This article provides an overview of the available literature on EM, with special emphasis on management strategies including lifestyle modification, nonpharmacologic, pharmacologic, procedural, and rehabilitative interventions. PubMed was searched using the advanced search function with the terms 'erythromelalgia AND therapies AND management' from database inception through 16 April 2026.</p><p><strong>Expert opinion: </strong>Management of EM is challenging as there is no cure. It requires an individualized step wise approach due to its heterogenous presentation and variable treatment responses. The primary goal of treatment is to control symptoms and maintain quality of life. In this article, we outline our treatment approach for management including an initial evaluation for underlying causes or associations and treating them if present. First-line therapies include lifestyle modifications, trigger avoidance, and trial of various topical therapies. If not fully responding to first line therapy, we consider initiation of systemic therapies and pain rehabilitative programs.</p>","PeriodicalId":12184,"journal":{"name":"Expert Opinion on Pharmacotherapy","volume":" ","pages":"1-12"},"PeriodicalIF":3.4000,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14656566.2026.2734121","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Erythromelalgia (EM) is a rare disorder predominantly affecting distal extremities characterized by episodes of painful burning erythema, often precipitated by heat and exercise. Treatment is challenging due to limited evidence and lack of guidelines.

Areas covered: This article provides an overview of the available literature on EM, with special emphasis on management strategies including lifestyle modification, nonpharmacologic, pharmacologic, procedural, and rehabilitative interventions. PubMed was searched using the advanced search function with the terms 'erythromelalgia AND therapies AND management' from database inception through 16 April 2026.

Expert opinion: Management of EM is challenging as there is no cure. It requires an individualized step wise approach due to its heterogenous presentation and variable treatment responses. The primary goal of treatment is to control symptoms and maintain quality of life. In this article, we outline our treatment approach for management including an initial evaluation for underlying causes or associations and treating them if present. First-line therapies include lifestyle modifications, trigger avoidance, and trial of various topical therapies. If not fully responding to first line therapy, we consider initiation of systemic therapies and pain rehabilitative programs.

红斑性肢痛的治疗:叙述回顾和专家意见。
红斑性肢痛(EM)是一种罕见的临床疾病,主要影响远端肢体,其特征是疼痛的灼烧性红斑发作,通常由高温和运动引起。尽管它对生活质量有重大影响,但目前尚无治疗这种复杂疾病的指南,而且由于证据有限,治疗仍然具有挑战性。涵盖领域:本文概述了EM的现有文献,特别强调了管理策略,包括生活方式改变,非药物,药物,程序和康复干预。使用高级搜索功能在PubMed上搜索“红斑性肢痛症及其治疗和管理”。没有日期限制,检索包括从数据库建立到2026年4月16日的文章。专家意见:由于无法治愈,EM的管理具有挑战性。由于其异质的表现和不同的治疗反应,它需要个性化的逐步明智的方法。治疗的主要目标是控制症状和维持生活质量。在本文中,我们概述了我们的治疗方法,包括对潜在原因或关联的初步评估,并在存在的情况下进行治疗。一线治疗包括生活方式的改变,避免触发,以及各种局部治疗的试验。如果不能完全响应一线治疗,我们考虑启动全身治疗和疼痛康复计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.60
自引率
3.10%
发文量
163
审稿时长
4-8 weeks
期刊介绍: Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书